Skip to content
PIL Logo

Zomig Rapimelt 2.5mg

Last Updated on eMC 25-Jan-2017 View changes  | AstraZeneca UK Limited Contact details

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Please click on the link to the left to view the PIL in PDF format.

Text only version for the visually impaired
Below is a text only representation of the Patient Information leaflet. The original may contain images or tables and can be viewed in PDF format using the link to the left. This PIL may be available from the RNIB in large print, Braille or audio CD. For further information please call the RNIB Medicine Leaflet line on 0800 198 5000. The product code(s) for this leaflet is/are: PL 17901/0076.

Zomig Rapimelt 2.5mg

Package leaflet: Information for the user

Zomig Rapimelt 2.5 mg orodispersible tablets


Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See Section 4.

What is in this leaflet:

1. What Zomig Rapimelt is and what it is used for
2. What you need to know before you take Zomig Rapimelt
3. How to take Zomig Rapimelt
4. Possible side effects
5. How to store Zomig Rapimelt
6. Contents of the pack and other information

1. What Zomig Rapimelt is and what it is used for

Zomig Rapimelt contains zolmitriptan and belongs to a group of medicines called triptans.

Zomig Rapimelt is used to treat migraine headache.

  • Migraine symptoms may be caused by swollen blood vessels in the head. Zomig Rapimelt is thought to reduce the widening of these blood vessels. This helps to take away the headache and other symptoms of a migraine attack, such as feeling or being sick (nausea or vomiting) and being sensitive to light and sound.
  • Zomig Rapimelt works only when a migraine attack has started. It will not stop you from getting an attack.

2. What you need to know before you take Zomig Rapimelt

Do not take Zomig Rapimelt:

  • If you are allergic to zolmitriptan or any of the other ingredients of this medicine (listed in Section 6).
  • If you have high blood pressure.
  • If you have ever had heart problems, including a heart attack, angina (chest pain caused by exercise or effort), Prinzmetal’s angina (chest pain which happens at rest) or have experienced heart related symptoms such as shortness of breath or pressure over the chest.
  • If you have had a stroke or short-lasting symptoms similar to stroke (transient ischaemic attack or TIA).
  • If you are at the same time taking some other medicines for migraine (e.g. ergotamine or ergot-type medicines like dihydroergotamine and methysergide) or other triptan medicines for migraine. See ‘Other medicines and Zomig Rapimelt’ for further information.

Do not take Zomig Rapimelt if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking Zomig Rapimelt.

Warnings and precautions

Talk to your doctor of pharmacist before taking Zomig Rapimelt:

  • If you are at risk of getting ischaemic heart disease (poor blood flow in the arteries of the heart). Your risk is greater if you smoke, have high blood pressure, high levels of cholesterol, diabetes or if anyone in your family has ischaemic heart disease.
  • If you have been told that you have Wolff-Parkinson-White Syndrome (a type of abnormal heart beat).
  • If you have ever had liver problems.
  • If you have headaches which are not like your usual migraine headache.
  • If you are taking any medicine for treatment of depression (see ‘Other medicines and Zomig Rapimelt’ for further information).

If you go into hospital tell the medical staff you are taking Zomig Rapimelt.

Zomig Rapimelt is not recommended for people aged over 65.

As with other migraine treatments, using too much Zomig Rapimelt can cause daily headaches or can make your migraine headaches worse. Ask your doctor if you think that this is the case for you. You may need to stop taking Zomig Rapimelt to correct the problem.

Children and adolescents

Zomig Rapimelt is not recommended in children and adolescents under 18 years.

Other medicines and Zomig Rapimelt

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes herbal medicines and medicines you buy without prescription.

In particular, tell your doctor if you are taking any of the following medicines:

Medicines for migraine

  • If you take a triptan other than Zomig Rapimelt (such as sumatriptan or naratriptan) leave 24 hours before taking Zomig Rapimelt.
  • After taking Zomig Rapimelt leave 24 hours before taking another triptan.
  • If you take medicines containing ergotamine or ergot-type medicines (such as dihydroergotamine or methysergide), leave 24 hours before taking Zomig Rapimelt.
  • After taking Zomig Rapimelt leave 6 hours before taking ergotamine or ergot-type medicines.

Medicines for depression

  • Mono-Amine Oxidase Inhibitors, also known as MAOIs (such as moclobemide).
  • SSRIs (selective serotonin reuptake inhibitors) such as fluoxetine, paroxetine, fluvoxamine or sertraline.
  • SNRIs (serotonin norepinephrine reuptake inhibitors) such as venlafaxine or duloxetine.

Other medicines

  • Cimetidine (for indigestion or stomach ulcers).
  • A quinolone antibiotic (such as ciprofloxacin).

You should not take the herbal remedy St. John’s wort (Hypericum perforatum) at the same time as this medicine. If you already take a St. John’s wort preparation, stop taking it and mention this to your doctor at your next visit.

Zomig Rapimelt with food and drink

You can take Zomig Rapimelt with or without food. It does not affect the way that Zomig Rapimelt works.

Pregnancy, breast-feeding and fertility

It is not known if taking Zomig Rapimelt during pregnancy is harmful. If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Driving and using machines

During a migraine attack your reactions may be slower than usual. Bear this in mind when you drive or use any tools or machines.

Zomig Rapimelt is unlikely to affect driving or using tools or machines. However, it may make you feel sleepy. Wait to see how Zomig Rapimelt affects you before you try these activities.

Zomig Rapimelt contains Aspartame (E951)

Zomig Rapimelt 2.5 mg orodispersible tablets contain aspartame, a source of phenylalanine, which may be harmful for people with phenylketonuria.

3. How to take Zomig Rapimelt

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor of pharmacist if you are not sure.

You can take this medicine as soon as a migraine headache starts. You can also take it once an attack is underway.

  • The recommended dose is one tablet (2.5 mg).
  • Peel the blister pack open as shown on the foil. Do not push the tablet through the foil.
  • Place the tablet on your tongue, where it will dissolve and be swallowed with the saliva. You do not have to take a drink of water in order to swallow your tablet.
  • You can take another tablet if the migraine is still present after two hours or if it returns within 24 hours.

If the tablets did not give you enough help with your migraine, tell your doctor. Your doctor may change your treatment.

Do not use more than the dose prescribed for you.

  • Do not use more than two doses in one day unless prescribed by your doctor.
  • The maximum daily dose is 10 mg.

If you take more Zomig Rapimelt than you should

If you have taken more Zomig Rapimelt than prescribed by your doctor, talk to your doctor or pharmacist straight away or go to the nearest hospital straight away. Take this medicine with you.

If you forget to take Zomig Rapimelt

  • Do not take a double dose to make up for a forgotten dose.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Some of the symptoms below could be part of the migraine attack itself.

If you notice any of the following serious side effects, stop taking Zomig Rapimelt and contact a doctor straight away:

Rare (may affect up to 1 in 1,000 people):

  • Allergic reactions including itchy rash (urticaria) and swelling of the face, lips, mouth, tongue and throat.

Very rare (may affect up to 1 in 10,000 people):

  • Angina (pain in the chest, often brought on by exercise), heart attack or spasm of the blood vessels of the heart. The signs include chest pain and shortness of breath.
  • Spasm of the blood vessels of the gut, which can cause damage to your gut. The signs include stomach pain or bloody diarrhoea.
  • Bleeding in the brain (cerebral bleeding) or stroke.

Other possible side effects include:

Common (may affect up to 1 in 10 people):

These side effects are usually mild and go away after a short time.

  • Abnormal sensations such as tingling in your fingers and toes or skin that is sensitive to touch.
  • Feeling sleepy, dizzy or warm.
  • Headache.
  • Uneven heart beat.
  • Feeling sick (nausea) or being sick (vomiting).
  • Stomach pain.
  • Dry mouth.
  • Muscle weakness or muscle pain.
  • Feeling weak.
  • Heaviness, tightness, pain or pressure in the throat, neck, arms and legs, or chest.
  • Problems swallowing.

Uncommon (may affect up to 1 in 100 people):

  • Very fast heart beat.
  • Slightly higher blood pressure.
  • Increase in the amount of water you pass (urine) or in how often you need to pass water.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, Website: By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Zomig Rapimelt

  • Keep this medicine out of the sight and reach of children.
  • Keep your medicine in the container it came in.
  • Do not use this medicine after the expiry date stated on the carton. The expiry date refers to the last day of that month.
  • Do not store above 30°C.
  • Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Zomig Rapimelt 2.5 mg orodispersible tablet contains

The active substance is zolmitriptan. Each tablet contains 2.5 mg of zolmitriptan.

The other ingredients are: aspartame (E951), citric acid anhydrous, silica colloidal anhydrous, crospovidone, magnesium stearate, mannitol (E421), microcrystalline cellulose, orange flavour (SN027512) and sodium hydrogen carbonate.

What Zomig Rapimelt 2.5 mg orodispersible tablets look like and contents of the pack

  • Zomig Rapimelt 2.5 mg orodispersible tablets are white, flat-faced, round and marked with the letter ‘Z’ on one side.
  • Zomig Rapimelt 2.5 mg orodispersible tablets come in peelable aluminium laminate blister packs containing 6 tablets.

Zomig may also be available as orodispersible 5 mg tablets, nasal spray 5 mg/dose and film-coated tablets 2.5 mg.

Marketing Authorisation Holder and Manufacturer

The Marketing Authorisation for Zomig Rapimelt 2.5 mg orodispersible tablets is held by

AstraZeneca UK Limited
600 Capability Green

Zomig Rapimelt 2.5 mg orodispersible tablets are manufactured by

AstraZeneca UK Limited
Silk Road Business Park
SK10 2NA

To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge:

0800 198 5000 (UK only)

Please be ready to give the following information:

Product name Zomig Rapimelt 2.5 mg

Reference number 17901/0076

This is a service provided by the Royal National Institute of Blind People.

This leaflet was last revised in: October 2016

© AstraZeneca 2016

Zomig Rapimelt is a trade mark of the AstraZeneca group of companies.

You can also get support and information about migraine from the

Migraine Action Association (UK)
Unit 6
Oakley Hay Lodge Business Park
Great Folds Road
Great Oakley
NorthantsNN18 9AS

CNS 16 0017

Company contact details

AstraZeneca UK Limited

Company image

Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU


+44 (0)1582 838 000

Medical Information e-mail
Medical Information Fax

+44 (0)1582 838 003


+44 (0)1582 836 000

Medical Information Direct Line

0800 783 0033

Customer Care direct line

+44 (0)1582 837 837

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients


Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue